Home / XBIT : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does XBIT make money? Does XBIT have pricing power? What's the Earnings Whisper? Will XBIT profit more as the business scales? What is XBIT's management track record? Is XBIT's current price justified?

XBiotech Inc.

$2.19 -$0.19 (-7.98%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$2.17

Day Range

$2.18$2.2

Year Range

$2.09$3.44

Market Cap

66.77M

AVG Volume

36.84K

Trailing/Forward PE

-1.48/-

PEG ratio

0.03

Dividend Yield

Next Earnings Date

Primary Exchange

NASDAQ

Revenue (USD)

XBIT Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0
24 Q1	0

Net Income (USD)

XBIT Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-6.73M
26 Q1	-5.5M
25 Q4	-26.89M
25 Q3	-6.01M
25 Q2	-1.76M
25 Q1	-10.88M
24 Q4	-10.51M
24 Q3	-5.01M
24 Q2	-13.01M
24 Q1	-10M

Operating Income (USD)

XBIT Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-6.15M
26 Q1	-6.27M
25 Q4	-29.75M
25 Q3	-6.05M
25 Q2	-6.34M
25 Q1	-13.55M
24 Q4	-8.75M
24 Q3	-7.9M
24 Q2	-14.97M
24 Q1	-10.85M

EBITDA (USD)

XBIT EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-4.72M
26 Q1	-5.12M
25 Q4	-26.44M
25 Q3	-5.48M
25 Q2	-1.29M
25 Q1	-10.32M
24 Q4	-9.91M
24 Q3	-4.36M
24 Q2	-12.6M
24 Q1	-9.35M

Cash Flows (USD)

XBIT Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-4.51M
26 Q1	-8.97M
25 Q4	-22.99M
25 Q3	-4.37M
25 Q2	-6.04M
25 Q1	-6.81M
24 Q4	-6.62M
24 Q3	-6.18M
24 Q2	-12M
24 Q1	-7.46M

EPS (USD)

XBIT EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0.22
26 Q1	-0.18
25 Q4	-0.88
25 Q3	-0.2
25 Q2	-0.06
25 Q1	-0.36
24 Q4	-0.34
24 Q3	-0.16
24 Q2	-0.43
24 Q1	-0.33

Expenses (USD)

XBIT Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	6.14M
26 Q1	6.27M
25 Q4	29.79M
25 Q3	6.16M
25 Q2	6.39M
25 Q1	13.64M
24 Q4	8.83M
24 Q3	8.24M
24 Q2	15.59M
24 Q1	11.11M

Cash & Debt (USD)

XBIT Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	109.53M
26 Q1	115.46M
25 Q4	125.55M
25 Q3	147.37M
25 Q2	152.94M
25 Q1	155.9M
24 Q4	172.68M
24 Q3	183.12M
24 Q2	188.53M
24 Q1	201.04M

Debt ratios

XBIT Debt ratios by quarter
Period	Debt ratios
26 Q2	2.62
26 Q1	3.01
25 Q4	2.88
25 Q3	5.46
25 Q2	5.91
25 Q1	4.19
24 Q4	4.49
24 Q3	5.66
24 Q2	5.43
24 Q1	6.7

Margins

XBIT Margins by quarter
Period	Margins
22 Q4	94.67%
22 Q3	87.2%
22 Q2	86.47%
22 Q1	57.4%
21 Q4	76.76%
21 Q3	75.44%
21 Q2	69.94%
21 Q1	52.49%
20 Q4	57.34%
20 Q3	10.65%

Return on Capital

XBIT Return on Capital by quarter
Period	Return on Capital
26 Q2	-5.24%
26 Q1	-4.08%
25 Q4	-19.16%
25 Q3	-3.6%
25 Q2	-1.01%
25 Q1	-6.23%
24 Q4	-5.77%
24 Q3	-2.61%
24 Q2	-6.61%
24 Q1	-4.78%

Shares Outstanding

XBIT Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	30.49M
26 Q1	30.49M
25 Q4	30.49M
25 Q3	30.49M
25 Q2	30.49M
25 Q1	30.49M
24 Q4	30.46M
24 Q3	30.47M
24 Q2	30.46M
24 Q1	30.44M

Dividends (USD)

XBIT Dividends (USD) by quarter
Period	Dividends (USD)
Jul 21	2.47

Employee Count

XBIT Employee Count by quarter
Period	Employee Count
2025	85
2024	92
2023	82
2022	85
2021	97
2020	91
2019	60
2018	56
2017	51
2016	106

Book Value Per Share (USD)

XBIT Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	4.21
26 Q1	4.43
25 Q4	4.6
25 Q3	5.48
25 Q2	5.68
25 Q1	5.73
24 Q4	5.98
24 Q3	6.3
24 Q2	6.46
24 Q1	6.87

Total Assets (USD)

XBIT Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	133.65M
26 Q1	139.84M
25 Q4	150.08M
25 Q3	172.42M
25 Q2	178.68M
25 Q1	181.86M
24 Q4	199.09M
24 Q3	209.85M
24 Q2	215.56M
24 Q1	227.86M

PE Ratio

XBIT PE Ratio by quarter
Period	PE Ratio
Mar 21	0.86
Mar 21	0.8
Feb 21	0.81
Feb 21	0.85
Feb 21	0.87
Feb 21	0.86
Jan 21	0.8
Jan 21	0.72
Jan 21	0.7
Jan 21	0.75
Dec 20	0.67
Dec 20	0.72
Dec 20	0.73
Dec 20	0.81
Dec 20	0.82
Nov 20	0.83
Nov 20	0.75
Nov 20	0.84
Nov 20	0.79
Oct 20	0.73
Oct 20	0.78
Oct 20	0.82
Oct 20	0.85
Oct 20	0.78
Sep 20	0.81
Sep 20	0.91
Sep 20	0.81
Sep 20	0.78
Aug 20	0.81
Aug 20	0.79
Aug 20	0.74
Aug 20	0.81
Jul 20	0.78
Jul 20	0.82
Jul 20	0.81
Jul 20	0.79
Jul 20	0.78
Jun 20	0.78
Jun 20	0.76
Jun 20	0.71
Jun 20	0.78
May 20	0.75
May 20	0.77
May 20	0.77
May 20	0.85
May 20	0.85
Apr 20	0.74
Apr 20	0.74
Apr 20	0.72
Apr 20	0.62
Mar 20	0.53
Mar 20	0.51

Free Cash Flow Yield

XBIT Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-61.16%
Sep 26	-60.88%
Aug 26	-59.01%
Aug 26	-58.75%
Aug 26	-58.24%
Aug 26	-61.21%
Jul 26	-62.31%
Jul 26	-61.21%
Jul 26	-61.21%
Jul 26	-60.68%
Jul 26	-60.41%
Jun 26	-59.64%
Jun 26	-60.15%
Jun 26	-59.38%
Jun 26	-58.63%
May 26	-57.42%
May 26	-57.18%
May 26	-56.49%
May 26	-53.61%
May 26	-51.72%
Apr 26	-52.54%
Apr 26	-53.61%
Apr 26	-56.6%
Apr 26	-56.12%
Mar 26	-58.1%
Mar 26	-55.18%
Mar 26	-57.09%
Mar 26	-33.28%
Feb 26	-34.61%
Feb 26	-33.86%
Feb 26	-31.93%
Feb 26	-33%
Jan 26	-31.16%
Jan 26	-29.19%
Jan 26	-30.44%
Jan 26	-30.55%
Jan 26	-32.86%
Dec 25	-31.67%
Dec 25	-31.29%
Dec 25	-32.59%
Dec 25	-31.54%
Nov 25	-34.46%
Nov 25	-34.31%
Nov 25	-29.63%
Nov 25	-35.97%
Oct 25	-35.82%
Oct 25	-32.75%
Oct 25	-33.8%
Oct 25	-33.14%
Oct 25	-31.88%
Sep 25	-31.17%
Sep 25	-30.94%
Sep 25	-30.61%
Sep 25	-28.82%
Aug 25	-26.64%
Aug 25	-26.3%
Aug 25	-26.72%
Aug 25	-35.52%
Aug 25	-36.4%
Jul 25	-36.14%
Jul 25	-34.81%
Jul 25	-36.65%
Jul 25	-32.62%
Jun 25	-37.05%
Jun 25	-41.49%
Jun 25	-39.29%
Jun 25	-35.77%
May 25	-36.4%
May 25	-36.52%
May 25	-34.12%
May 25	-38.24%
May 25	-36.28%
Apr 25	-32.92%
Apr 25	-32.58%
Apr 25	-29.21%
Apr 25	-33.38%
Mar 25	-30.9%
Mar 25	-27.85%
Mar 25	-28.94%
Mar 25	-29.48%
Feb 25	-27.21%
Feb 25	-32.04%
Feb 25	-29.29%
Feb 25	-30.9%
Jan 25	-27.69%
Jan 25	-26.25%
Jan 25	-25.08%
Jan 25	-24.69%
Jan 25	-21.67%
Dec 24	-25.21%
Dec 24	-15.01%
Dec 24	-13.78%
Dec 24	-14.97%
Nov 24	-12.59%
Nov 24	-14.03%
Nov 24	-14.38%
Nov 24	-10.67%
Nov 24	-10.96%
Oct 24	-11.23%
Oct 24	-10.67%

Price to Sales

XBIT Price to Sales by quarter
Period	Price to Sales
Apr 24	798.45
Apr 24	815.7
Apr 24	938.46
Apr 24	832.95
Mar 24	824.83
Mar 24	760.92
Mar 24	599.6
Mar 24	649.31
Mar 24	649.31
Feb 24	654.39
Feb 24	598.59
Feb 24	596.56
Feb 24	550.9
Jan 24	426.11
Jan 24	471.77
Jan 24	507.28
Jan 24	408.87
Dec 23	405.82
Dec 23	397.71
Dec 23	471.77
Dec 23	423.07
Dec 23	403.79
Nov 23	363.21
Nov 23	386.04
Nov 23	399.73
Nov 23	64.26
Oct 23	61.49
Oct 23	58.03
Oct 23	60.42
Oct 23	63.03
Sep 23	63.34
Sep 23	67.03
Sep 23	69.95
Sep 23	74.1
Sep 23	73.18
Aug 23	87.01
Aug 23	76.87
Aug 23	78.25
Aug 23	43.53
Jul 23	43.97
Jul 23	47.96
Jul 23	45.1
Jul 23	47.87
Jun 23	51.51
Jun 23	52.38
Jun 23	53.68
Jun 23	47.26
Jun 23	44.31
May 23	47.44
May 23	42.93
May 23	29.05
May 23	25.43
Apr 23	26.11
Apr 23	26.26
Apr 23	27.02
Apr 23	27.4
Mar 23	26.19
Mar 23	25.28
Mar 23	25.96
Mar 23	12.38
Mar 23	12.42
Feb 23	11.94
Feb 23	13.12
Feb 23	14.24
Feb 23	15.39
Jan 23	16.46
Jan 23	15.57
Jan 23	17.28
Jan 23	13.4
Dec 22	13.01
Dec 22	11.42
Dec 22	11.49
Dec 22	11.83
Dec 22	12.61
Nov 22	11.79
Nov 22	12.61
Nov 22	13.01
Nov 22	9.81
Oct 22	9.81
Oct 22	9.31
Oct 22	10.08
Oct 22	10.44
Sep 22	9.97
Sep 22	10.25
Sep 22	11.05
Sep 22	11.38
Sep 22	11.19
Aug 22	11.85
Aug 22	12.62
Aug 22	14.16
Aug 22	11.25
Jul 22	11.06
Jul 22	11.34
Jul 22	11.17
Jul 22	12.47
Jul 22	12.07
Jun 22	12.54
Jun 22	10.97
Jun 22	12.13
Jun 22	12.77

Price/Operating Cashflow

XBIT Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Aug 22	2.53
Jul 22	2.48
Jul 22	2.55
Jul 22	2.51
Jul 22	2.8
Jul 22	2.71
Jun 22	2.82
Jun 22	2.47
Jun 22	2.72
Jun 22	2.87
May 22	2.69
May 22	2.7
May 22	2.76
May 22	3.04
Apr 22	3.39
Apr 22	3.36
Apr 22	3.64
Apr 22	3.81
Apr 22	3.98
Mar 22	3.88
Mar 22	4.19
Mar 22	3.85
Mar 22	4.03
Feb 22	4.22
Feb 22	4.17
Feb 22	4.34
Feb 22	4.17
Jan 22	4.48
Jan 22	4.39
Jan 22	4.97
Jan 22	4.85
Dec 21	4.77
Dec 21	4.84
Dec 21	4.94
Dec 21	5
Dec 21	4.73
Nov 21	5.48
Nov 21	5.43
Nov 21	6.31
Nov 21	5.84
Oct 21	5.38
Oct 21	5.17
Oct 21	4.85
Oct 21	4.75
Oct 21	4.86
Sep 21	5.26
Sep 21	5.9
Sep 21	5.76
Sep 21	5.84
Aug 21	5.92
Aug 21	5.71
Aug 21	5.86

Price to Book

XBIT Price to Book by quarter
Period	Price to Book
Sep 26	0.52
Sep 26	0.52
Aug 26	0.54
Aug 26	0.54
Aug 26	0.55
Aug 26	0.51
Jul 26	0.5
Jul 26	0.51
Jul 26	0.51
Jul 26	0.52
Jul 26	0.52
Jun 26	0.53
Jun 26	0.52
Jun 26	0.53
Jun 26	0.54
May 26	0.55
May 26	0.55
May 26	0.56
May 26	0.53
May 26	0.55
Apr 26	0.55
Apr 26	0.53
Apr 26	0.51
Apr 26	0.51
Mar 26	0.49
Mar 26	0.52
Mar 26	0.5
Mar 26	0.43
Feb 26	0.41
Feb 26	0.42
Feb 26	0.45
Feb 26	0.43
Jan 26	0.46
Jan 26	0.49
Jan 26	0.47
Jan 26	0.47
Jan 26	0.43
Dec 25	0.45
Dec 25	0.46
Dec 25	0.44
Dec 25	0.45
Nov 25	0.41
Nov 25	0.42
Nov 25	0.48
Nov 25	0.41
Oct 25	0.41
Oct 25	0.45
Oct 25	0.44
Oct 25	0.45
Oct 25	0.47
Sep 25	0.48
Sep 25	0.48
Sep 25	0.48
Sep 25	0.51
Aug 25	0.56
Aug 25	0.56
Aug 25	0.55
Aug 25	0.51
Aug 25	0.5
Jul 25	0.5
Jul 25	0.52
Jul 25	0.49
Jul 25	0.55
Jun 25	0.49
Jun 25	0.44
Jun 25	0.46
Jun 25	0.51
May 25	0.5
May 25	0.5
May 25	0.53
May 25	0.46
May 25	0.49
Apr 25	0.46
Apr 25	0.47
Apr 25	0.52
Apr 25	0.46
Mar 25	0.49
Mar 25	0.55
Mar 25	0.53
Mar 25	0.52
Feb 25	0.56
Feb 25	0.47
Feb 25	0.52
Feb 25	0.49
Jan 25	0.55
Jan 25	0.58
Jan 25	0.61
Jan 25	0.62
Jan 25	0.7
Dec 24	0.6
Dec 24	1.01
Dec 24	1.1
Dec 24	1.02
Nov 24	1.21
Nov 24	1.08
Nov 24	1.06
Nov 24	1.17
Nov 24	1.14
Oct 24	1.11
Oct 24	1.17

No video analysis for this stock yet. Request one from our team.

News: XBIT

globenewswire.com · 15 Jun 2026

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

IND Application for V-SPINE Study Completes 30-Day FDA Review Without Clinical Hold, Clearing Path for U.S. Patient Enrollment

AI Analysis

XBiotech Inc.

Video analysis: XBIT

News: XBIT

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

Similar companies